Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
52
BOMXF Quote, Financials, Valuation and Earnings
Last price:
$1.65
Seasonality move
:
4.42%
Day range:
$1.65 - $1.67
52-week range:
$1.39 - $2.26
Dividend yield:
7.59%
P/E ratio:
10.84x
P/S ratio:
4.41x
P/B ratio:
2.60x
Volume:
282.8K
Avg. volume:
24.1K
1-year change:
-17.09%
Market cap:
$927.3M
Revenue:
$207.9M
EPS (TTM):
$0.15
Analysts' Opinion
-
Consensus RatingBolsa Mexicana de Valores SAB de CV has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Bolsa Mexicana de Valores SAB de CV has an estimated downside of -- from its current price of $1.65.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $1.65.
Fair Value
-
According to the consensus of 0 analysts, Bolsa Mexicana de Valores SAB de CV has -- downside to fair value with a price target of -- per share.
BOMXF vs. S&P 500
-
Over the past 5 trading days, Bolsa Mexicana de Valores SAB de CV has underperformed the S&P 500 by -2.69% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Bolsa Mexicana de Valores SAB de CV does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Bolsa Mexicana de Valores SAB de CV has grown year-over-year revenues for 5 quarters straight. In the most recent quarter Bolsa Mexicana de Valores SAB de CV reported revenues of $55.8M.
Earnings Growth
-
Bolsa Mexicana de Valores SAB de CV has grown year-over-year earnings for 3 quarters straight. In the most recent quarter Bolsa Mexicana de Valores SAB de CV reported earnings per share of $0.04.
Enterprise value:
787.2M
EV / Invested capital:
1.99x
Price / LTM sales:
4.41x
EV / EBIT:
5.65x
EV / Revenue:
3.70x
PEG ratio (5yr expected):
1.37x
EV / Free cash flow:
7.99x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
5.17x
Gross Profit (TTM):
$135.5M
Return On Assets:
18.04%
Net Income Margin (TTM):
40.7%
Return On Equity:
20.81%
Return On Invested Capital:
21.03%
Operating Margin:
52.21%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $194.7M | $203.5M | $212.6M | $54.7M | $55.8M | |
| Gross Profit | $137M | $132.3M | $135.5M | $34.6M | $36.4M | |
| Operating Income | $108.9M | $99.8M | $101.2M | $26.8M | $29.1M | |
| EBITDA | $138.3M | $135.1M | $152.2M | $30M | $32.2M | |
| Diluted EPS | $0.15 | $0.14 | $0.15 | $0.03 | $0.04 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $175.1M | $191.7M | $206.7M | -- | $202.7M | |
| Total Assets | $372.5M | $404.4M | $424.5M | -- | $445.6M | |
| Current Liabilities | $36.9M | $38.4M | $39.6M | -- | $49.7M | |
| Total Liabilities | $48.5M | $50.9M | $50.1M | -- | $71.3M | |
| Total Equity | $324M | $353.5M | $374.5M | -- | $374.2M | |
| Total Debt | -- | -- | -- | -- | $21.5M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2022-06-30 | 2023-06-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $82.2M | $100.7M | $107.8M | $22.9M | $30M | |
| Cash From Investing | -$2M | -$5.3M | -$9M | -$1.4M | -$5.6M | |
| Cash From Financing | -$78.5M | -$89.2M | -$107.4M | -$71.2M | -$88.6M | |
| Free Cash Flow | $80.3M | $95.7M | $98.6M | $21.2M | $24.5M | |
BOMXF
Sector
Market Cap
$927.3M
$694.9M
Price % of 52-Week High
73.01%
87.97%
Dividend Yield
7.59%
2.23%
Shareholder Yield
--
3.88%
1-Year Price Total Return
-17.09%
8.55%
Beta (5-Year)
0.935
0.737
Dividend yield:
7.59%
Annualized payout:
$0.13
Payout ratio:
--
Growth streak:
2 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$1.68
200-day SMA
Sell
Level
$1.77
Bollinger Bands (100)
Buy
Level
1.56 - 1.68
Chaikin Money Flow
Buy
Level
2M
20-day SMA
Buy
Level
$1.63
Relative Strength Index (RSI14)
Buy
Level
50.68
ADX Line
Buy
Level
8.31
Williams %R
Neutral
Level
-46.0043
50-day SMA
Buy
Level
$1.64
MACD (12, 26)
Buy
Level
0.01
25-day Aroon Oscillator
Buy
Level
52
On Balance Volume
Neutral
Level
2.4M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (12.3485)
Buy
CA Score
(Annual)
Level (2.5532)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (5)
Buy
Ohlson Score
Level (-6.3075)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Bolsa Mexicana de Valores SAB de CV or Grupo BMV is a public securities exchange operating in Mexico but with listings from both Mexican and foreign issuers. Its services include trading, listing, custody, clearing, and settlement, as well as counterparty services and data sales. The company's largest sources of revenue include cash equities, derivatives, over-the-counter activity, issuers, custody, and information services. Much of the company's revenue is driven by trading volume. The company's largest costs are personnel and technology-related. As with most exchanges, Grupo BMV heavily relies on technology to deliver its services.
Stock Forecast FAQ
In the current month, BOMXF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The BOMXF average analyst price target in the past 3 months is --.
-
Where Will Bolsa Mexicana de Valores SAB de CV Stock Be In 1 Year?
According to analysts, the consensus estimate is that Bolsa Mexicana de Valores SAB de CV share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Bolsa Mexicana de Valores SAB de CV?
Analysts are divided on their view about Bolsa Mexicana de Valores SAB de CV share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Bolsa Mexicana de Valores SAB de CV is a Sell and believe this share price will rise from its current level to --.
-
What Is Bolsa Mexicana de Valores SAB de CV's Price Target?
The price target for Bolsa Mexicana de Valores SAB de CV over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is BOMXF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Bolsa Mexicana de Valores SAB de CV is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of BOMXF?
You can purchase shares of Bolsa Mexicana de Valores SAB de CV via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Bolsa Mexicana de Valores SAB de CV shares.
-
What Is The Bolsa Mexicana de Valores SAB de CV Share Price Today?
Bolsa Mexicana de Valores SAB de CV was last trading at $1.65 per share. This represents the most recent stock quote for Bolsa Mexicana de Valores SAB de CV. Yesterday, Bolsa Mexicana de Valores SAB de CV closed at $1.65 per share.
-
How To Buy Bolsa Mexicana de Valores SAB de CV Stock Online?
In order to purchase Bolsa Mexicana de Valores SAB de CV stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
